Whole Blood Dendritic Cell Cytokine Production Assay
Author:
Woodberry Tonia,
Loughland Jessica Rita,
Minigo GabrielaORCID
Reference23 articles.
1. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392(6673):245–252. https://doi.org/10.1038/32588
2. Gerrits JH, Athanassopoulos P, Vaessen LM, Klepper M, Weimar W, van Besouw NM (2007) Peripheral blood manipulation significantly affects the result of dendritic cell monitoring. Transpl Immunol 17(3):169–177. https://doi.org/10.1016/j.trim.2006.11.006
3. Chowdhury F, Johnson P, Williams AP (2010) Enumeration and phenotypic assessment of human plasmacytoid and myeloid dendritic cells in whole blood. Cytometry A 77(4):328–337. https://doi.org/10.1002/cyto.a.20872
4. Loughland JR, Minigo G, Burel J, Tipping PE, Piera KA, Amante FH, Engwerda CR, Good MF, Doolan DL, Anstey NM, McCarthy JS, Woodberry T (2016) Profoundly reduced CD1c+ myeloid dendritic cell HLA-DR and CD86 expression and increased tumor necrosis factor production in experimental human blood-stage malaria infection. Infect Immun 84(5):1403–1412. https://doi.org/10.1128/IAI.01522-15
5. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN (2002) Characterization of human blood dendritic cell subsets. Blood 100(13):4512–4520. https://doi.org/10.1182/blood-2001-11-0097